Disclosure Quest - Search SEC Filings

Name	Type of Offering	Accepted Date
Poseida Therapeutics, Inc. See All Filings	D	2023-08-11 16:48:17 UTC
Amount To Be Raised $24,999,999 Associated Brokers / Dealers N/A CIK Number 0001661460 Filed Document 0001661460-23-000003 Exclusions or Exemptions 506b Accepted Date 2023-08-11 16:48:17 UTC Type of Offering D Industry Biotechnology Principal Place of Business CALIFORNIA Revenue or Assets Decline to Disclose Type of Security Equity
Poseida Therapeutics, Inc. See All Filings	D	2019-04-22 14:51:42 UTC
Amount To Be Raised $150,000,000 Associated Brokers / Dealers N/A CIK Number 0001661460 Filed Document 0001661460-19-000003 Exclusions or Exemptions 506b Accepted Date 2019-04-22 14:51:42 UTC Type of Offering D Industry Biotechnology Principal Place of Business CALIFORNIA Revenue or Assets Decline to Disclose Type of Security Equity
Poseida Therapeutics, Inc. See All Filings	D	2018-04-03 15:24:51 UTC
Amount To Be Raised $30,499,990 Associated Brokers / Dealers N/A CIK Number 0001661460 Filed Document 0001661460-18-000001 Exclusions or Exemptions 506b Accepted Date 2018-04-03 15:24:51 UTC Type of Offering D Industry Biotechnology Principal Place of Business CALIFORNIA Revenue or Assets Decline to Disclose Type of Security Equity
Poseida Therapeutics, Inc. See All Filings	D	2017-08-02 21:50:43 UTC
Amount To Be Raised $15,000,000 Associated Brokers / Dealers N/A CIK Number 0001661460 Filed Document 0001661460-17-000001 Exclusions or Exemptions 506b Accepted Date 2017-08-02 21:50:43 UTC Type of Offering D Industry Biotechnology Principal Place of Business CALIFORNIA Revenue or Assets Decline to Disclose Type of Security Equity
Poseida Therapeutics, Inc. See All Filings	D	2015-12-23 00:00:00 UTC
Amount To Be Raised $36,033,230 Associated Brokers / Dealers N/A CIK Number 0001661460 Filed Document 0001661460-15-000001 Exclusions or Exemptions 506b Accepted Date 2015-12-23 00:00:00 UTC Type of Offering D Industry Biotechnology Principal Place of Business CALIFORNIA Revenue or Assets Decline to Disclose Type of Security Equity